(VGT)

VGT offers slightly lower fees and broader tech sector exposure, but is more top-heavy and excludes major tech names like Amazon, Google, and Meta. QQQ provides access to the full Magnificent 7, is le...

VGT's extreme concentration in its top three holdings undermines the diversification benefit I expect from an ETF. Current tech sector valuations are historically high, leaving little room for further...

The Nasdaq Composite (^IXIC 0.52%) closed Wednesday at 19,146.81 -- a staggering 29.5% rally from its 52-week intraday low of 14,784.03 on April 7.

The markets are extending their gains in this midweek session. Technology stocks are buoying wider market sentiment.

The markets came out of the gate higher across the board but those gains have evaporated.

Tech stocks are joining in on today's market gains on positive trade developments between the U.S.

MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced that an abstract on abenacianine for injection (VGT-309) wi...

The markets remain under pressure, including technology stocks, as the Fed meets to discuss interest rates.

Tech stocks remain under pressure, including a 2% decline in Apple stock, while the Dow Jones Industrial Average is eking out a slight gain.

It's a chaotic time in the market, that's for sure. The roller-coaster ride of 2025 has left many investors feeling confused and not a little bit fearful.